Pediatric Vaccines

The Food and Drug Administration granted emergency use authorization Friday for Pfizer/BioNTech COVID-19 vaccines in children aged 5 to 11. Final concurrence from the Centers for Disease Control and Prevention is expected this week, making shots available to more than 28 million children. 

In data submitted for review, Pfizer reported the vaccine was found to be 90.7% effective in preventing COVID-19 in the age group. No serious side effects were reported to date, though experts have noted the small sample size of 3,100 children.

Uptake is expected to be slower than previous rollouts. A recent survey found 27% of parents would have their children vaccinated once available, 33% said they would wait and see, and 30% said they would definitely not.

To date, 78% of Americans over 12 have received at least one dose (including 97% of those over 65 years old). Meanwhile, the US is averaging around 70,000 new cases per day, with just over 1,400 daily deaths.

Leave a Reply

Your email address will not be published. Required fields are marked *